Sort
51,593 grants matching “hepatitis”
Chlamydial Vaccine Testing in Mice and Guinea Pigs
$481,931Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U19 · FY2020 · AI
Brain Glucosensing Neurons in Health and Diabetes
$481,879Barry E Levin · Veterans Biomedical Research Institute · R01 · FY2010 · DK
DAT-Emulating target trials with big data to strengthen the evidence base for the clinical management of opioid use disorder
$481,852Bohdan Nosyk · Simon Fraser University · R01 · FY2024 · DA
Functional Anatomy of Neuroimmune Interactions
$481,828Paul E. Sawchenko · Salk Institute For Biological Studies · R01 · FY2014 · NS
Mechanisms of luminal protein targeting in kidney and hepatic epithelial cells
$481,795Anne Muesch · Albert Einstein College Of Medicine · R01 · FY2013 · DK
Lipid Aldehyde and Ethanol Induced Liver Damage
$481,789Dennis Petersen · University Of Colorado Denver · R37 · FY2017 · AA
Mechanisms of Regulation of Cannabinoid Disposition
$481,748Nina Isoherranen · University Of Washington · P01 · FY2020 · DA
HCV SPECIFIC T CELL RESPONSES
$481,745Research Inst Nationwide Children'S Hosp · R01 · FY2002 · AI
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
$481,696Yu Chen · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Stratification of Non-alcoholic Fatty Liver Disease using the SAFE Score
$481,685W. Ray Kim · Stanford University · R01 · FY2021 · DK
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$481,659Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
BIOLOGY OF PEDIATRIC HEPATITIS C INFECTION
$481,619New York University School Of Medicine · R01 · FY2001 · DA
Effect of Alcohol on Obesity Related Liver Disease
$481,606Arun J Sanyal · Virginia Commonwealth University · R01 · FY2014 · AA
Alternatively activated macrophages during helminth infection
$481,577Victor J Torres · New York University School Of Medicine · R01 · FY2021 · AI
Alternatively activated macrophages during helminth infection
$481,577Victor J Torres · New York University School Of Medicine · R01 · FY2020 · AI
Alternatively activated macrophages during helminth infection
$481,577Png Loke · New York University School Of Medicine · R01 · FY2017 · AI
Alternatively activated macrophages during helminth infection
$481,577Victor J Torres · New York University School Of Medicine · R01 · FY2019 · AI
Inhibition of EGF Receptor Prevents and Reverses Non-Alcoholic Fatty Liver Disease
$481,570George K Michalopoulos · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
microRNA Uncoupling of Protein and Transcript Expression in Liver Regeneration
$481,554Clifford J. Steer · University Of Minnesota · R01 · FY2010 · DK
Reducing Youth Drug Related HIV/STD Risk in Thailand
$481,551Johns Hopkins University · R01 · FY2005 · DA
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
$481,473Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2024 · CA
Regulation of Hepatic and Peripheral Glucose Metabolism
$481,457Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2008 · DK
HEPATIC CARCINOGENESIS INDUCED BY HEPATITIS B VIRUS PreS2 MUTANT
$481,425Tien-Sze Benedict Yen · University Of Southern California · P01 · FY2009 · CA
Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases
$481,343Mark A Kay · Stanford University · R01 · FY2016 · AI
Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases
$481,343Mark A Kay · Stanford University · R01 · FY2017 · AI